Efficient redirection of nk cells by genetic modification with chemokine receptors ccr4 and ccr2b

HIGHLIGHTS

• who: Frederik Fabian Feigl et al. from the Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany Chair of Tissue Engineering and Regenerative Medicine (TERM), University Hospital of Wu00fcrzburg have published the paper: Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B, in the Journal: (JOURNAL)
• what: Using the NK cell line NK-92 as well as primary NK cells from peripheral blood the authors show that genetically engineered NK cells can be efficiently redirected using from different immune cell lineages and migrate towards chemokines such as CCL22 or . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.